Generic name: NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN 50ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE ANTIGEN 25ug in 0.5mL
Dosage form: suspension, for intramuscular injection
Drug class: Bacterial vaccines
Medically reviewed by Drugs.com. Last updated on Jan 6, 2022.
For intramuscular use only.
Shake the syringe immediately before use to form a homogeneous suspension. Do not use the vaccine if it cannot be resuspended. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if particulate matter or discoloration is found.
Administer BEXSERO as a 0.5-mL intramuscular injection into the deltoid muscle of the upper arm.
More about Bexsero (meningococcal group B vaccine)
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- FDA approval history
- Drug class: bacterial vaccines
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.